TOP TIERMARKET NEWSWIRE
News & sentiment

KALARIS THERAPEUTICS (KLRS) — News & AI sentiment

KALARIS THERAPEUTICS (KLRS) news roundup. 6 stories in the past week, 6 over 30 days. Average 30-day sentiment is 44.3/100. No insider transactions filed in the last 90 days. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →
24h stories
0
7d stories
6
avg sentiment 44.3/100
30d stories
6
avg sentiment 44.3/100
Insider net (90d)
$0
0 buys · 0 sells
Congress (90d)
0
0 buys · 0 sells

KLRS news in the last 24 hours, 7 days, 30 days and 90 days

How much KLRS coverage the wire captured in each window, with the average AI sentiment across those stories. Counts are of stories that have cleared the 4-hour public delay.

Time windowKLRS storiesAvg AI sentimentRead
Last 24 hours0—no coverage
Last 7 days644.3/100KLRS headlines →
Last 30 days644.3/100KLRS headlines →
Last 90 days746/100KLRS headlines →

Latest stories on KLRS

2d ago
3d ago
Citizens cuts Kalaris stock price target to $20 on trial delay
Investing.com Analyst Ratings34 · bearishanalyst
3d ago
3d ago
4d ago
4d ago
Aug 31
Aug 11
Kalaris Therapeutics GAAP EPS of -$0.48 in-line
Seeking Alpha52 · neutralearnings
Aug 11
Aug 11
Aug 11
Aug 11
Kalaris Therapeutics stock falls despite naming new CFO
Investing.com Markets42 · neutralgeneral
Jul 20
Kalaris appoints Liisa Bayko as CFO
Seeking Alpha55 · neutralgeneral
Jul 20
Jul 20
Jul 20
Jul 20
Jul 17
Jul 17
Jul 17
Jul 17
Jul 17
Jul 6
Jul 6
Jul 6
Open KLRS in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →